Regis (RGS) EBITDA (2009 - 2026)

Regis (RGS) has reported EBITDA for 18 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 13.86% year-over-year to $5.7 million; the trailing twelve-month figure through Mar 2026 stood at $20.3 million (up 1440.77% YoY), and the FY2025 full-year result was $22.5 million, up 286.34% from the prior year.
• EBITDA fell to $5.7 million in Q1 2026 per RGS's latest filing, from $6.2 million in the prior quarter.
• Across five years, EBITDA topped out at $8.4 million in Q2 2023 and bottomed at -$22.2 million in Q1 2022.
• Historically, EBITDA has averaged $1.6 million across 5 years, with a median of $4.1 million in 2024.
• The sharpest annual moves came in 2022 and 2024: EBITDA soared 782.38% in 2022, then sank 269.11% in 2024.
• Over 5 years, EBITDA stood at $3.3 million in 2022, then surged by 43.51% to $4.8 million in 2023, then climbed by 15.02% to $5.5 million in 2024, then grew by 12.73% to $6.2 million in 2025, then dropped by 7.75% to $5.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $5.7 million, $6.2 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.